Skip to main content
SpringerLink
Log in

Inflammatory bowel disease in patients with Hirschsprung’s disease: a systematic review and meta-analysis

  • Original Article
  • Published:
Pediatric Surgery International Aims and scope Submit manuscript

Abstract

Aim and objectives

Hirschsprung-associated enterocolitis (HAEC) continues to be an important cause of morbidity in patients with Hirschsprung’s disease (HSCR). HAEC can occur at any time during the course of the disease. The reported incidence of HAEC before surgery ranges from 6 to 50%, and after surgery, it ranges from 2 to 35%. HAEC and inflammatory bowel disease (IBD) have similar clinical presentation including diarrhea, hematochezia, and abdominal pain. In recent years, isolated cases of IBD have been reported in patients who had surgical treatment for HSCR. The exact pathogenesis of HAEC or IBD is not known. However, both conditions are characterized by an abnormal intestinal mucosal barrier function, which may be a common pathway. The purpose of this meta-analysis was to determine the clinical presentation and outcome in patients with HSCR who developed IBD after pull-through operation.

Materials and methods

A systematic literature search for relevant articles was performed in four databases using the combinations of the following terms “inflammatory bowel disease”, “Crohn/Crohn’s disease”, “ulcerative colitis”, and “Hirschsprung disease/Hirschsprung’s disease” for studies published between 1990 and 2017. The relevant cohorts of HSCR associated with IBD were systematically searched for clinical presentation and outcomes.

Results

14 studies met defined inclusion criteria, reporting a total of 66 patients who had HSCR associated with IBD. Mean age at first operation for HSCR was 5.8 months, mean age at diagnosis of IBD was 7.7 years, and the majority of patients were male (73%). The extent of aganglionosis was total colonic aganglionosis in 41% of patients, long segment in 45%, and rectosigmoid in 14%. The majority of patients underwent a Duhamel procedure (84%) for HSCR. The distribution of IBD was Crohn’s disease in 72.3% of patients, ulcerative colitis in 16.9%, and others in 10.8%. Eight articles (47 patients) reported about HAEC, and 22 patients (47%) had experienced HAEC after surgery for HSCR.

Conclusion

Male patients with extensive colonic aganglionosis who continue to suffer from postoperative HAEC after a Duhamel procedure are more susceptible to develop IBD. Recognition of IBD may be important in the long-term follow-up of HSCR patients who have had postoperative HAEC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Puri P (2011) Hirschsprung’s disease. In: Puri P (ed) Newborn surgery. Hodder Arnold, London, pp 554–565

    Chapter  Google Scholar 

  2. Engum SA, Grosfeld JL (2004) Long-term results of treatment of Hirschsprung’s disease. Semin Pediatr Surg 13:273–285

    Article  PubMed  Google Scholar 

  3. Hackam DJ, Filler RM, Pearl RH (1998) Enterocolitis after the surgical treatment of Hirschsprung’s disease: risk factors and financial impact. J Pediatr Surg 33:830–833

    Article  CAS  PubMed  Google Scholar 

  4. Szigethy E, McLafferty L, Goyal A (2010) Inflammatory bowel disease. Child Adolesc Psychiatr Clin N Am 19:301–318, ix

    Article  PubMed  Google Scholar 

  5. de Souza HS, Fiocchi C (2016) Immunopathogenesis of IBD: current state of the art. Nat Rev Gastroenterol Hepatol 13:13–27

    Article  CAS  PubMed  Google Scholar 

  6. Guan Q, Zhang J (2017) Recent advances: the imbalance of cytokines in the pathogenesis of inflammatory bowel disease. Mediat Inflamm 2017:4810258

    Google Scholar 

  7. Freeman JJ, Rabah R, Hirschl RB, Maspons A, Meier D, Teitelbaum DH (2015) Anti-TNF-alpha treatment for post-anastomotic ulcers and inflammatory bowel disease with Crohn’s-like pathologic changes following intestinal surgery in pediatric patients. Pediatr Surg Int 31:77–82

    Article  PubMed  Google Scholar 

  8. Kessler BH, So HB, Becker JM (1999) Crohn’s disease mimicking enterocolitis in a patient with an endorectal pull-through for Hirschsprung’s disease. J Pediatr Gastroenterol Nutr 29:601–603

    Article  CAS  PubMed  Google Scholar 

  9. Arumugam R, Brandt ML, Jaksic T, Gilger M (2000) Crohn’s disease presenting as chronic constipation: a case report. Clin Pediatr (Phila) 39:369–371

    Article  CAS  Google Scholar 

  10. Coran AG (1990) A personal experience with 100 consecutive total colectomies and straight ileoanal endorectal pull-throughs for benign disease of the colon and rectum in children and adults. Ann Surg 212:242–247 (discussion 247–248)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Deising A, Veerappan G, Betteridge J (2011) Crohn’s disease presenting in an adult surgically treated for Hirschsprung’s disease. Inflamm Bowel Dis 17:51–52

    Article  Google Scholar 

  12. Kim HY, Kim TW (2017) Crohn’s disease with ankylosing spondylitis in an adolescent patient who had undergone long ileo-colonic anastomosis for Hirschsprung’s disease as an infant. Intest Res 15:133–137

    Article  PubMed  PubMed Central  Google Scholar 

  13. Fremond ML, Viala J, Treton X, Roy M, Berrebi D, Gottrand F et al (2014) Digestive perianastomotic ulcerations and Crohn’s disease. J Crohns Colitis 8:1624–1631

    Article  PubMed  Google Scholar 

  14. Muller CO, Rossignol G, Montalva L, Viala J, Martinez-Vinson C, Mosca A et al (2016) Long-term outcome of laparoscopic Duhamel procedure for extended Hirschsprung’s disease. J Laparoendosc Adv Surg Tech A 26:1032–1035

    Article  PubMed  Google Scholar 

  15. Cucino C, Sonnenberg A (2001) The comorbid occurrence of other diagnoses in patients with ulcerative colitis and Crohn’s disease. Am J Gastroenterol 96:2107–2112

    Article  CAS  PubMed  Google Scholar 

  16. Dray X, Sokol H, Vahedi K, Lavergne-Slove A, Marteau P (2007) Pure ileal Crohn’s disease without colonic involvement after a long ileo-colonic anastomosis (Lester Martin procedure) for Hirschsprung’s disease: an argument favoring a specific sensitivity of the ileum in a subset of patients with Crohn’s disease. Inflamm Bowel Dis 13:243–244

    Article  PubMed  Google Scholar 

  17. Levin DN, Marcon MA, Rintala RJ, Jacobson D, Langer JC (2012) Inflammatory bowel disease manifesting after surgical treatment for Hirschsprung disease. J Pediatr Gastroenterol Nutr 55:272–277

    Article  PubMed  Google Scholar 

  18. Pena A, Elicevik M, Levitt MA (2007) Reoperations in Hirschsprung disease. J Pediatr Surg 42:1008–1013 (discussion 1013–1004)

    Article  PubMed  Google Scholar 

  19. Ikeuchi H, Kusunoki M, Yamamura T, Utsunomiya J (1997) A case of Crohn’s disease following Hirschsprung disease. J Jpn Pract Surg Soc 58:622–625

    Article  Google Scholar 

  20. Imamura A, Puri P, O’Briain DS, Reen DJ (1992) Mucosal immune defence mechanisms in enterocolitis complicating Hirschsprung’s disease. Gut 33:801–806

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Pontarelli EM, Ford HR, Gayer CP (2013) Recent developments in Hirschsprung’s-associated enterocolitis. Curr Gastroenterol Rep 15:340

    Article  PubMed  Google Scholar 

  22. Korzenik JR, Podolsky DK (2006) Evolving knowledge and therapy of inflammatory bowel disease. Nat Rev Drug Discov 5:197–209

    Article  CAS  PubMed  Google Scholar 

  23. Loftus EV, Jr (2004) Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 126:1504–1517

    Article  PubMed  Google Scholar 

  24. Binder V (2004) Epidemiology of IBD during the twentieth century: an integrated view. Best Pract Res Clin Gastroenterol 18:463–479

    Article  PubMed  Google Scholar 

  25. Hanauer SB (2006) Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis 12(Suppl 1):S3–S9

    Article  PubMed  Google Scholar 

  26. Ahmad T, Satsangi J, McGovern D, Bunce M, Jewell DP (2001) Review article: the genetics of inflammatory bowel disease. Aliment Pharmacol Ther 15:731–748

    Article  CAS  PubMed  Google Scholar 

  27. Kusunoki M, Ikeuchi H, Yanagi H, Shoji Y, Yamamura T (1997) Stapled fistulectomy to treat enteroenteric fistulas in Crohn’s disease. Surg Today 27:574–575

    Article  CAS  PubMed  Google Scholar 

  28. Elhalaby EA, Coran AG, Blane CE, Hirschl RB, Teitelbaum DH (1995) Enterocolitis associated with Hirschsprung’s disease: a clinical-radiological characterization based on 168 patients. J Pediatr Surg 30:76–83

    Article  CAS  PubMed  Google Scholar 

  29. Surana R, Quinn FM, Puri P (1994) Short-gut syndrome: intestinal adaptation in a patient with 12 cm of jejunum. J Pediatr Gastroenterol Nutr 19:246–249

    Article  CAS  PubMed  Google Scholar 

  30. Quinn FM, Surana R, Puri P (1994) The influence of trisomy 21 on outcome in children with Hirschsprung’s disease. J Pediatr Surg 29:781–783

    Article  CAS  PubMed  Google Scholar 

  31. Laughlin DM, Friedmacher F, Puri P (2012) Total colonic aganglionosis: a systematic review and meta-analysis of long-term clinical outcome. Pediatr Surg Int 28:773–779

    Article  PubMed  Google Scholar 

  32. Shikhare G, Kugathasan S (2010) Inflammatory bowel disease in children: current trends. J Gastroenterol 45:673–682

    Article  PubMed  Google Scholar 

  33. Mundt E, Bates MD (2010) Genetics of Hirschsprung disease and anorectal malformations. Semin Pediatr Surg 19:107–117

    Article  PubMed  Google Scholar 

  34. Bonen DK, Cho JH (2003) The genetics of inflammatory bowel disease. Gastroenterology 124:521–536

    Article  CAS  PubMed  Google Scholar 

  35. Lacher M, Fitze G, Helmbrecht J, Schroepf S, Berger M, Lohse P et al (2010) Hirschsprung-associated enterocolitis develops independently of NOD2 variants. J Pediatr Surg 45:1826–1831

    Article  PubMed  Google Scholar 

  36. Lidar M, Langevitz P, Shoenfeld Y (2009) The role of infection in inflammatory bowel disease: initiation, exacerbation and protection. Isr Med Assoc J 11:558–563

    PubMed  Google Scholar 

  37. Mattar AF, Coran AG, Teitelbaum DH (2003) MUC-2 mucin production in Hirschsprung’s disease: possible association with enterocolitis development. J Pediatr Surg 38:417–421 (discussion 417–421)

    Article  PubMed  Google Scholar 

  38. Johansson ME, Hansson GC (2013) Mucus and the goblet cell. Dig Dis 31:305–309

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Children’s Research Centre, Our Lady’s Children’s Hospital, Dublin, Ireland

    H. Nakamura & P. Puri

  2. Department of Chemical and Biological Engineering, Princeton University, Princeton, NJ, USA

    T. Lim

  3. School of Medicine and Medical Science and Conway Institute of Biomolecular and Biomedical Research University College Dublin, Dublin, Ireland

    P. Puri

Authors
  1. H. Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Puri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. Puri.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nakamura, H., Lim, T. & Puri, P. Inflammatory bowel disease in patients with Hirschsprung’s disease: a systematic review and meta-analysis. Pediatr Surg Int 34, 149–154 (2018). https://doi.org/10.1007/s00383-017-4182-4

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00383-017-4182-4

Keywords

Search

Navigation